Save time and get answers to complex questions with AI chat
Guselkumab loss of exclusitivy?Stribild expiry date?Allergan's patent for latisse expired?Pramlintide acetate price?Zemdri nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for Crestor
Crestor (rosuvastatin) was first approved and launched in 2003, with its initial market launch tied to early 2003 in major regions such as the U.S. and Europe.
Regulatory approval for rosuvastatin occurred in 2003, and the market launch followed shortly after approval in key markets.
Market launch in 2003 is the starting point for counting forward to later exclusivity and patent-driven timelines. Those timelines are often tracked via drug patent records—DrugPatentWatch.com compiles such information for rosuvastatin products and related filings. [1]
Other Questions About Crestor :